TABLE 1.
Breakdown of the patient cohort by site and high‐dose planning target volume (PTV1) range
| Primary site | Number of patients | Range of PTV1 dose, Gy |
|---|---|---|
| Oropharynx | 21 | 60–70 |
| Oral cavity | 8 | 60–70 |
| Larynx | 3 | 70 |
| Hypopharynx | 8 | 60‐68 |
| Nasopharynx | 10 | 60‐70 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.